Clinical Trials
16 trialsNCT07279935 2026-03-19
REVIVE
AstraZeneca
Phase 4 Not yet recruiting
NCT05689671 2026-03-10
ANTELOPE
Charite University, Berlin, Germany
Phase 4 Active not recruiting
NCT06951841 2025-04-30
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
China Medical University, China
Phase 4 Not yet recruiting
NCT06931145 2025-04-23
Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Peking Union Medical College Hospital
Phase 4 Not yet recruiting
NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
NCT06357598 2024-04-10
PILOT
The Affiliated Hospital of Qingdao University
Phase 4 Unknown
NCT05071703 2023-10-06
Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 4 Completed
NCT03092986 2019-03-08
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 4 Completed
NCT03799601 2019-01-10
ALTER-L013
Tongji Hospital
Phase 4 Unknown
NCT02151149 2018-09-24
ABOUND 70+
Celgene
Phase 4 Completed
NCT02299765 2017-11-27
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Sichuan University
Phase 4 Terminated
NCT02804646 2016-06-21
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
Anhui Provincial Hospital
Phase 4 Unknown
NCT01317615 2016-03-30
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Novartis
Phase 4 Completed
NCT02031601 2016-03-29
TCL-1
Qilu Hospital of Shandong University
Phase 4 Unknown
NCT00883675 2013-12-18
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Maestro Clinical, Inc.
Phase 4 Completed
NCT01020786 2013-08-27
A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients
Eli Lilly and Company
Phase 4 Completed